Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Kalaris Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Berkeley Heights, NJ, United States

  1. PrincipalsBrett R HagenChief Accounting OfficerMatthew FeinsodChief Medical OfficerMatthew GallChief Financial Officerand 2 more
  2. CompanyKalaris Therapeutics, Inc.Berkeley Heights, NJ, United States
  3. Phone line+1 (650) 249-2727General business
Request a quote

Kalaris Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker KLRS) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 5

Chair & board

Srinivas AkkarajuDirector (Board)

Finance

Brett R HagenChief Accounting Officer
Matthew GallChief Financial Officer
Everyone else on file (2)
Matthew FeinsodChief Medical Officer
Andrew OxtobyOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Brett R Hagen — Chief Accounting Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Matthew Feinsod — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Matthew Gall — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Andrew Oxtoby — Officer (see SEC filing)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers